|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▼
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
DOLUTEGRAVIR AND RILPIVIRINE |
J05AR21 |
IT
|
I
|
|
|
|
VALID
|
|
DORAVIRINE |
J05AG06 |
IT
|
I
|
24-04-2020 |
|
|
VALID
|
|
DOSTARLIMAB |
L01FF07 |
IT
|
I
|
19-10-2021 |
EMEA/H/C/005204 |
21-04-2021 |
VALID
|
|
DROPERIDOL |
N05AD08 |
IT
|
I
|
|
None |
|
VALID
|
|
DROSPIRENONE AND ESTETROL |
G03AA18 |
IT
|
I
|
19-10-2021 |
EMEA/H/C/005336 |
19-05-2021 |
VALID
|
|
DROTRECOGIN ALFA (ACTIVATED) |
B01AD10 |
IT
|
I
|
|
None |
|
VALID
|
|
DURVALUMAB |
L01FF03 |
IT
|
I
|
26-02-2020 |
|
|
VALID
|
|
DUVELISIB |
L01EM04 |
IT
|
I
|
19-10-2021 |
EMEA/H/C/005381 |
19-05-2021 |
VALID
|
|
DYDROGESTERONE AND ESTROGEN |
G03FA14 |
IT
|
I
|
|
None |
|
VALID
|
|
EBOLA VACCINES |
J07BX02 |
IT
|
I
|
05-06-2020 |
EMEA/H/C/004554 |
11-11-2019 |
VALID
|
|
EFAVIRENZ |
J05AG03 |
IT
|
I
|
|
None |
11-02-2002 |
VALID
|
|
EFGARTIGIMOD ALFA |
L04AA58 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005849 |
10-08-2022 |
VALID
|
|
ELBASVIR AND GRAZOPREVIR |
J05AP54 |
IT
|
I
|
|
|
|
VALID
|
|
ELIVALDOGENE AUTOTEMCEL |
N07XX00 |
IT
|
I
|
19-10-2021 |
EMEA/H/C/003690 |
16-07-2021 |
VALID
|
|
ELOTUZUMAB |
L01FX08 |
IT
|
I
|
27-01-2022 |
EMEA/H/C/003967 |
11-05-2016 |
VALID
|
|
ELRANATAMAB |
L01FX32 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/005908 |
07-12-2023 |
VALID
|
|
EMTRICITABINE |
J05AF09 |
IT
|
I
|
14-11-2018 |
|
|
VALID
|
|
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE |
J05AR17 |
IT
|
I
|
|
|
|
VALID
|
|
EMTRICITABINE, TENOFOVIR ALAFENAMIDE AND RILPIVIRINE |
J05AR19 |
IT
|
I
|
|
|
|
VALID
|
|
EMTRICITABINE, TENOFOVIR ALAFENAMIDE, DARUNAVIR AND COBICISTAT |
J05AR22 |
IT
|
I
|
|
|
|
VALID
|
|
EMTRICITABINE, TENOFOVIR ALAFENAMIDE, ELVITEGRAVIR AND COBICISTAT |
J05AR18 |
IT
|
I
|
|
|
|
VALID
|
|
EMTRICITABINE, TENOFOVIR DISOPROXIL AND EFAVIRENZ |
J05AR06 |
IT
|
I
|
|
|
|
VALID
|
|
EMTRICITABINE, TENOFOVIR DISOPROXIL AND RILPIVIRINE |
J05AR08 |
IT
|
I
|
|
|
|
VALID
|
|
EMTRICITABINE, TENOFOVIR DISOPROXIL, ELVITEGRAVIR AND COBICISTAT |
J05AR09 |
IT
|
I
|
|
|
|
VALID
|
|
ENFORTUMAB VEDOTIN |
L01FX13 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005392 |
13-04-2022 |
VALID
|
|
ENTECAVIR |
J05AF10 |
IT
|
I
|
|
None |
|
VALID
|
|
EPIRUBICIN |
L01DB03 |
IT
|
I
|
|
None |
|
VALID
|
|
EPOETIN BETA |
B03AX01 |
IT
|
I
|
|
None |
|
VALID
|
|
EPOPROSTENOL |
B01AC09 |
IT
|
I
|
|
|
|
VALID
|
|
EPTIFIBATIDE |
B01AC16 |
IT
|
I
|
|
|
|
VALID
|
|
EPTINEZUMAB |
N02CD05 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005287 |
24-01-2022 |
VALID
|
|
ERENUMAB |
N02CD01 |
IT
|
I
|
31-05-2023 |
|
|
VALID
|
|
ERIBULIN |
L01XX41 |
IT
|
I
|
|
None |
|
VALID
|
|
ERLOTINIB |
L01EB02 |
IT
|
I
|
13-07-2023 |
|
|
VALID
|
|
ERTAPENEM |
J01DH03 |
IT
|
I
|
|
None |
|
VALID
|
|
ERYTHROPOIETIN |
B03XA01 |
IT
|
I
|
|
None |
16-01-2009 |
VALID
|
|
ESKETAMINE |
N06AX27 |
IT
|
I
|
05-06-2020 |
EMEA/H/C/004535 |
18-12-2019 |
VALID
|
|
ESTRADIOL |
G03CA03 |
IT
|
I
|
07-02-2024 |
|
|
VALID
|
|
ETRANACOGENE DEZAPARVOVEC |
B06XX00 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/004827 |
20-02-2023 |
VALID
|
|
ETRASIMOD |
L04AE05 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/006007 |
16-02-2024 |
VALID
|
|
ETRAVIRINE |
J05AG04 |
IT
|
I
|
|
None |
|
VALID
|
|
EVEROLIMUS |
L01EG02 |
IT
|
I
|
21-02-2020 |
|
|
VALID
|
|
EVEROLIMUS |
L04AH02 |
IT
|
I
|
|
None |
|
VALID
|
|
EVINACUMAB |
C10AX17 |
IT
|
I
|
19-10-2021 |
EMEA/H/C/005449 |
17-06-2021 |
VALID
|
|
EXAGAMGLOGENE AUTOTEMCEL |
B06AX05 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/005763 |
09-02-2024 |
VALID
|
|
EXENATIDE |
A10BJ01 |
IT
|
I
|
|
|
|
VALID
|
|
FARICIMAB |
S01LA09 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005642 |
15-09-2022 |
VALID
|
|
FAT EMULSIONS |
B05BA02 |
IT
|
I
|
03-03-2021 |
|
|
VALID
|
|
FEDRATINIB |
L01XE57 |
IT
|
I
|
01-06-2021 |
EMEA/H/C/005026 |
08-02-2021 |
VALID
|
|
FENTANYL |
N02AB03 |
IT
|
I
|
|
None |
|
VALID
|
